S. Robert Witherspoon, M.D.

CURRICULUM VITAE

S. Robert Witherspoon, MD

WORK HISTORY:

Retina Institute of Texas, PA; Vitreous and Retina Diagnosis and Surgery: 

Associate Aug. 1, 2009 – July 31, 2011

Partner Aug. 1, 2011 – Present

EDUCATION:

Oregon Health and Science University/Casey Eye Institute and Devers Eye Institute, Portland, OR Fellowship in Vitreoretinal Surgery and Disease, 2007-2009

University of Texas-Southwestern/Parkland Memorial Hospital, Dallas, TX, Residency in Ophthalmology, 2004-2007

University of Texas-Southwestern/Parkland Memorial Hospital, Dallas, TX, Internship Internal Medicine, 2003-2004

Saint Louis University School of Medicine, St. Louis, MO, Doctorate of Medicine, Summa cum Laude 1999-2003

University of Missouri, Columbia, MO, Bachelor of Science, Magna cum Laude 1995-1999

CERTIFICATION:

USMLE Step 1: 2001, 99th percentile

USMLE Step 2: 2002, 99th percentile

USMLE Step 3: 2004, 99th percentile

American Board of Ophthalmology: 2008

            Written qualifying examination 99th percentile

HONORS AND AWARDS:

University of Texas-Southwestern Medical Center, Department of Ophthalmology, Outstanding Service Award for Exceptional Contribution and Dedication to the Ophthalmology Residency Program;  2012, 2013, 2014, 2015, 2016, 2017, 2018

Dallas Academy of Ophthalmology:

President 2016-2017

Vice-President 2015-2016

Program Chairperson 2014-2015

Secretary 2013-2014

University of Texas-Southwestern Alumni Day Research Award; First Place, 2007

University of Texas-Southwestern Alumni Day Research Award; Second Place, 2006

Summa cum Laude, Saint Louis University, 2003

Alpha Omega Alpha, Junior Year 2002-2003

Alpha Sigma Nu National Jesuit Honor Society, 2003

Saint Louis University Alumni Distinguished Student Award, 2003 (Awarded to a senior student of high moral character and scholastic achievement who has manifested service to patients, fellow students, and the School of Medicine)

Donald W. Bussmann Award, 2003 (Awarded to the medical student who demonstrates outstanding scholarship and performance on one’s surgical rotation)

AOA Student Research Forum Award; First Place Clinical Research Division, 2003

Surgery Student of the Year, Saint Louis University, 2002 (Voted on by the Surgery Department faculty to the top medical student performance on one’s surgery rotation)

Invited Speaker; White Coat Ceremony for class of 2006, 2002

Saint Louis University Alpha Omega Alpha Research Forum; first place, Clinical Research Division, 2001

Magna cum Laude, University of Missouri, 1999

Honors Scholar, University of Missouri, 1999

SERVICE TO THE COMMUNITY:

Volunteer North Texas Veterans Hospital Clinical Surgeon 2009-Present

Medical Mission, Srikiran Institute of Ophthalmology; Kakinada, India 2006

Hope Medical Mission, Nicaragua 2003

O’Speaker; Greene County Medical Society Pre-Med Conference, 2002

Saint Louis University School of Medicine Admissions Committee Member and Tour Guide, 2002

HIV Educator for St. Louis high schools, 2001

Child Abuse Prevention, 1999-2001

COMMITTEES:

Saint Louis University School of Medicine Admissions Committee member, 2000-2003

Saint Louis University School of Medicine Student Professional Conduct Council member, 2000-2002

PUBLICATIONS:

JOURNALS:

Ali ZK, Whitson JT, Mootha VV, Witherspoon SR, Joseph JA, Joseph AM, Hynan LS, Cavanagh HD.  “Glaucoma in patients with corneal dystrophy .” Eye Contact Lens.  2011 Nov;37(6):332-6.

Chan-Kai BT, Yeh S, Weleber RG, Francis PJ, Adamus G, Witherspoon SR, Lauer AK.  “Electroretinographic findings in transplant chorioretinopathy.” Clin Ophthalmol.2010 Jul 30;4:777-83.

Yeh S, Forooghian F, Faia LJ, Weichel ED, Wong WT, Sen HN, Chan-Kai BT, Witherspoon SR, Lauer AK, Chew EY, Nussenblatt RB.  “Fundus autofluorescence changes in cytomegalovirus retinitis.” Retina. 2010 Jan:30(1):42-50.

Yeh S, Cebulla CM, Witherspoon SR, Emerson GG, Emerson MV, Suhler EB, Albini TA, Flaxel CJ.  “Management of fluocinolone implant dissociation during implant exchange.” Arch Ophthalmol. 2009 Sep;127(9):1218-21.

Dinges WL, Witherspoon SR, Itani KM, Garg A, Peterson DM.  “Blepharoptosis and external ophthalmoplegia associated with long-term antiretroviral therapy.” Clin Infect Dis. 2008 Sep 15;47(6):845-52

Witherspoon SR, Callanan D.  “Celiac disease presenting as a Xerophthalmic fundus.” Retina. 2008 Mar;28(3):525-6.

Charton, JW, Witherspoon SR, Jones FR, Marple B, Itani, K.  “Natural Killer/T-cell Lymphoma Masquerading as Orbital Cellulitis.” Ophthal Plast Reconstr Surg. 2008 Mar-Apr;24(2):143-5.

Witherspoon SR, Hogan RN, Petroll WM, Mootha VV, “Slitlamp, Confocal, and Light Microscopic Findings of Corneal Siderosis.” Cornea. 2007 Dec;26(10):1270-2

Witherspoon SR, Lauer AK.  “Ocular Injuries Caused by Conductive Energy Weapons” Conductive Energy Weapons, Ed: Kroll, M. Springer

Witherspoon CD, Morris R, Phillips R, Kuhn F, Nelson S, Witherspoon SR, “Severe combined anterior and posterior segment trauma.” Ocular Trauma: Principals and Practice, Ed: Kuhn F, Pieramici D. Thieme, New York, pp264-272, 2002.

ABSTRACTS AND POSTERS:

Witherspoon SR, Dinges W, Itani K. “Ptosis and External Ophthalmoplegia Associated With Chronic Antiretroviral Therapy in Patients with HIV”.  ARVO, 2007

Williams P, Witherspoon SR, Callanan, D.  “The use of topical Nepafenac for the treatment of center involving diabetic macular edema”.  ARVO, 2007

Witherspoon SR, Jones FR, Marple B, Itani K. “Natural Killer/T-cell Lymphoma Masquerading as Orbital Cellulitis” 37th Annual ASOPRS Scientific Symposium in association with the American Academy of Ophthalmology annual meeting, 2006. 

Witherspoon SR, Blomquist PH, “The Changing Microbiologic Spectrum of Preseptal and Orbital Cellulitis: Emergence of Methicillin-Resistant Staphylococcus aureus”.  ARVO, 2006. 

Witherspoon SR, Hogan RN “Pathologic findings of choroidal melanoma in patients with HIV.” American Academy of Ophthalmology, 2005. 

McHenry JG, Witherspoon SR “Linezolid and optic neuropathy.” American Academy of Ophthalmology, 2005. 

Witherspoon SR, Kooner KS “Ocular associations found during diabetes screening examinations.” ARVO, 2005. 

Witherspoon CD, Morris R, Herring J, Kuhn F, Nelson S, Witherspoon SR, “Surgical management of traction maculopathies.”  Oslo Symposium in Ophthalmology, 2000. 

SCIENTIFIC PRESENTATIONS:

Witherspoon SR, Chan-Kai B, Weleber R, Watzke R, Lauer A.  “Atypical Acute Retinal Pigment Epitheliitis.” 2008 ASRS Annual Meeting (Fluoroscein Angiography Presentation). 

Witherspoon SR, Chan-Kai B, Flaxel C. “Shooting Baskets in the Wrong Hoop” 2008 Annual Retina Society Meeting (Fluoroscein Angiography Presentation). 

Chan-Kai B, Witherspoon SR, Weleber R, Lauer A. “Electroretinographic Findings and Autoretinal Antibodies in Transplant Chorioretinopathy.” 2008 ASRS Annual Meeting (Paper).

Yeh S, Forooghian F, Weichel ED, Wong WT, Faja LJ, Chan-Kai BT, Witherspoon SR, Lauer AK, Chew EY, Nussenblatt RB.  “Fundus autofluorescence imaging in the evaluation of cytomegalovirus retinitis.” 2008 ASRS Annual Meeting (Paper). 

Witherspoon SR, Blomquist PH. “Changing microbiologic spectrum of cellulitis.” Texas Ophthalmological Society Annual Meeting, 2006. 

Witherspoon, SR, Mootha, VV, “Procurement of amniotic membrane.” Srikiran Institute of Ophthalmology Continuing Medical Education.  Ocular Surface Disorders.  Kakinada, India 2006. 

Witherspoon SR. “The use of temporary keratoprosthesis for surgical management of advanced infectious endophthalmitis.”  Saint Louis University, Alpha Omega Alpha Research Competition 2001. 

Witherspoon SR, Witherspoon, CD, Morris R, Kuhn F. “Penetrating ocular nail gun injuries.” International Society for Ocular Trauma Symposium.  Montreal, 2000.

Co-Investigator.  The effect of genotype and environmental risk factors on treatment response to intravitreal Lucentis (ranibizumab) for neovascular AMD.  Investigator Sponsored.  Phase IV Clinical Trial.  Oregon Health & Science University, 2007-present. 

Co-Investigator, Phase II Multicenter, Randomized, Double-Masked, Placebo Controlled, Dose-Comparison Study of the Safety and Efficacy of Fenretinide in the Treatment of Geographic Atrophy in Subjects With Age-Related Macular Degeneration.  Oregon Health & Science University, 2007-present,

Sub-Investigator.  Phase II Multicenter, Randomized study of the Efficacy of Ciliary Neurotrophic Factor delivered via Encapsulated Cell Technology (ECT) product for the treatment of visual loss associated with retinitis pigmentosa, 2007-present.

 

Copyright © 2002-2006 Retina Institute of Texas, PA
Web Hosting by OmicronWave Technologies, LLC